PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  05/27 11:12:05 am EDT
53.84 USD   -0.29%
08:18aPFIZER INC : Berenberg sticks Neutral
MD
07:42aViiV Healthcare commits to grant voluntary licence for patents relating to cabotegravir long-acting for PrEP to Medicines Patent Pool
AQ
02:49a4D pharma Plans Phase 2 Trial for Metastatic Urothelial Carcinoma Maintenance Therapy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tokyo hits record 10,000 COVID cases, Japan over 50,000 for first time

01/22/2022 | 04:29am EDT
COVID-19 pandemic in Tokyo

TOKYO (Reuters) -Tokyo recorded its fourth record number of daily COVID-19 infections on Saturday, breaking above 10,000, while Japan's exceeded 50,000 for the first time as the Omicron variant continues to spread rapidly.

The capital had 11,227 new coronavirus cases, the local government said a day after it reinstated curbs https://www.reuters.com/world/asia-pacific/japan-poised-widen-covid-19-controls-omicron-drives-record-infections-2022-01-19 on mobility and business activity through Feb. 13.

Tokyo's case count, exceeding Friday's 9,699, were more than double the 4,561 logged a week earlier.

Three people in Tokyo died of COVID-19 and 12 were in serious condition on Saturday, the Tokyo government said.

Some 34.3% of hospital beds in the capital were being used by coronavirus patients. A rise in the occupancy rate to 50% would warrant a state of emergency https://www.reuters.com/world/asia-pacific/japan-infections-surge-so-does-risk-pandemic-fatigue-2022-01-21 with more severe restrictions, local officials have said.

Osaka prefecture announced 7,375 infections, a second consecutive record, and two deaths.

Infections nationwide totalled at least 50,200 as nearly 30 of Japan's 47 prefectures set records, broadcaster FNN reported.

As of Friday, 78.7% of Japan's population had been fully vaccinated, but only 1.5% had received a booster shot, according to the Prime Minister's Office.

The health ministry on Friday approved https://www.reuters.com/world/asia-pacific/pfizer-says-has-approval-japan-covid-vaccine-children-aged-5-11-2022-01-21 the use of the Pfizer vaccine for children aged five to 11 in an effort to ramp up the vaccination rate.

(Reporting by Kantaro Komiya; Editing by Raju Gopalakrishnan and William Mallard)


© Reuters 2022
All news about PFIZER, INC.
08:18aPFIZER INC : Berenberg sticks Neutral
MD
07:42aViiV Healthcare commits to grant voluntary licence for patents relating to cabote..
AQ
02:49a4D pharma Plans Phase 2 Trial for Metastatic Urothelial Carcinoma Maintenance Therapy
MT
05/26ZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect
05/26Pfizer Receives US FDA Fast Track Designation for Ervogastat/Clesacostat Combination to..
MT
05/26Malawi Among 5 First Five African Countries to Benefit From Pfizer Health Accord
AQ
05/26Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for th..
BU
05/26Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for th..
CI
05/26Pfizer Launches 'An Accord for a Healthier World' to Improve Health Equity for 1.2 Bill..
AQ
05/26Supreme Court says watchdogs should pay fees
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 662 M - -
Net cash 2022 15 298 M - -
P/E ratio 2022 9,01x
Yield 2022 3,00%
Capitalization 303 B 303 B -
EV / Sales 2022 2,77x
EV / Sales 2023 3,69x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 53,99 $
Average target price 57,66 $
Spread / Average Target 6,80%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-8.57%302 932
JOHNSON & JOHNSON4.90%472 231
ROCHE HOLDING AG-12.16%282 336
ELI LILLY AND COMPANY13.48%282 164
ABBVIE INC.11.20%266 074
NOVO NORDISK A/S-4.82%242 093